Archives
SGLT2 Inhibitors Benefit Broad Range of Heart Failure Patients
Risk for cardiovascular death, hospitalization for heart failure reduced regardless of left ventricular ejection fraction
Cardiovascular Benefits of Statins Outweigh Low Risk for Muscle Symptoms
Only one of 15 muscle symptom-related reports by study participants assigned to statins believed to be due to statins
Polypill Cuts Cardiovascular Event Risk in Seniors With Recent MI
Polypill comprising aspirin, ramipril, atorvastatin effective for secondary prevention of cardiovascular disease in older adults
Dapagliflozin Cuts CV Risk in Heart Failure With Preserved LVEF
Risk reduced for primary outcome of worsening heart failure or cardiovascular death
Acetazolamide Helps Treat Volume Overload in Heart Failure
Rate of successful decongestion higher with addition of acetazolamide to loop diuretic in patients with acute decompensated heart failure
Pathogenic Germline Variants ID’d in Patients With Lung Cancer
About 15 percent of patients diagnosed with lung cancer had PGVs, most of which were potentially clinically actionable
Most Women With Lung Cancer Report Sexual Dysfunction
Little or no interest in sexual activity reported by majority of patients surveyed
Diabetic Macular Edema Outcomes Compared for Aflibercept, Bevacizumab
Outcomes at two years comparable among patients with diabetic macular edema receiving aflibercept monotherapy, bevacizumab first
Headaches in Teens During Pandemic Tied to Depression, Anxiety
Among teens with headache, 27 percent reported worsening of headaches, while 10 percent had new onset of headache
Genetic Mutations May Help Predict Survival in Parkinson Disease
Among patients with Parkinson disease, SNCA or GBA mutations associated with shorter survival compared with no mutations
